Artificial intelligence and machine learning in cell-free-DNA-based diagnostics
Genome Research · 2025-01 · 35 (1) · 1-19
DOI: 10.1101/gr.278413.123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genome Research, online erschienen am 22.01.2025. Verfasst von W H Adrian Tsui und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Novostics, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Machine Learning, Cell-Free Nucleic Acids, Artificial Intelligence. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Innovation and Technology Commission of the Hong Kong SAR Government, Li Ka Shing Foundation.
Abstract (Originalsprache)
The discovery of circulating fetal and tumor cell-free DNA (cfDNA) molecules in plasma has opened up tremendous opportunities in noninvasive diagnostics such as the detection of fetal chromosomal aneuploidies and cancers and in posttransplantation monitoring. The advent of high-throughput sequencing technologies makes it possible to scrutinize the characteristics of cfDNA molecules, opening up the fields of cfDNA genetics, epigenetics, transcriptomics, and fragmentomics, providing a plethora of biomarkers. Machine learning (ML) and/or artificial intelligence (AI) technologies that are known for their ability to integrate high-dimensional features have recently been applied to the field of liquid biopsy. In this review, we highlight various AI and ML approaches in cfDNA-based diagnostics. We first introduce the biology of cell-free DNA and basic concepts of ML and AI technologies. We then discuss selected examples of ML- or AI-based applications in noninvasive prenatal testing and cancer liquid biopsy. These applications include the deduction of fetal DNA fraction, plasma DNA tissue mapping, and cancer detection and localization. Finally, we offer perspectives on the future direction of using ML and AI technologies to leverage cfDNA fragmentation patterns in terms of methylomic and transcriptional investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Novostics, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong SAR, China.
- Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
- Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
- State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
- Center for Novostics, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong SAR, China; loym@cuhk.edu.hk.
ORCID-Profile: Peiyong Jiang
Förderung
- Innovation and Technology Commission of the Hong Kong SAR Government
- Li Ka Shing Foundation
Zitieren
APA
Tsui, W. H. A., Ding, S. C., Jiang, P., & Lo, Y. M. D. (2025). Artificial intelligence and machine learning in cell-free-DNA-based diagnostics. Genome Research, 35(1), 1-19. https://doi.org/10.1101/gr.278413.123
Vancouver
Tsui WHA, Ding SC, Jiang P, Lo YMD. Artificial intelligence and machine learning in cell-free-DNA-based diagnostics. Genome Research. 2025;35(1):1-19. doi:10.1101/gr.278413.123
BibTeX
@article{Tsui2025,
author = {Tsui, W H Adrian and Ding, Spencer C and Jiang, Peiyong and Lo, Y M Dennis},
title = {Artificial intelligence and machine learning in cell-free-DNA-based diagnostics},
journal = {Genome Research},
year = {2025},
volume = {35},
number = {1},
pages = {1--19},
doi = {10.1101/gr.278413.123}
}
EUVIMED